Information Provided By: 
Fly News Breaks for May 3, 2016
CYH
May 3, 2016 | 07:40 EDT
As previously reported, BofA/Merrill downgraded Community Health to Underperform from Neutral. Analyst Kevin Fischbeck said Q1 EBITDA was disappointing and cut his estimates below the guidance range. The analyst does not see volumes accelerating and is skeptical the company can turn around HMA assets in the near-term enough to hit margin targets. Fischbeck cut his price target on Community Health shares to $14 from $21.
News For CYH From the Last 2 Days
CYH
Apr 25, 2024 | 09:47 EDT
CYH
Apr 25, 2024 | 07:41 EDT
Oppenheimer lowered the firm's price target on Community Health to $4.50 from $5.50 and keeps an Outperform rating on the shares following quarterly results. The firm notes Community Health maintained its 2024 outlook. Overall, at these levels, Oppenheimer continues to see attractive upside for long-term investors.
CYH
Apr 24, 2024 | 16:23 EDT
Reports Q1 revenue $3.14B, consensus $3.09B. On a same-store basis, admissions increased 3.8% and adjusted admissions increased 1.9%, compared to the same period in 2023. The company said, "We were pleased with our first quarter performance compared to both prior year and prior quarter. Progress was demonstrated on key operational and strategic priorities, and we remain focused on building further momentum as we pursue the opportunities available to us this year"
